March 15, 2024
Loading...
You are here:  Home  >  'Amgen'  -  Page 4
Latest

Amgen shrugs off tough quarter, announces plans for new plant in North Carolina

By   /  Friday, August 6th, 2021  /  Banking & Finance, Earnings, East Ventura County, Health Care & Life Science, Latest news, Subscriber content, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen shrugs off tough quarter, announces plans for new plant in North Carolina

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen reports Q2 earnings decline

By   /  Tuesday, August 3rd, 2021  /  Banking & Finance, Earnings, East Ventura County, Health Care & Life Science, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen reports Q2 earnings decline

Amgen saw a 73% decline in net earnings in the second quarter of 2021, the company announced Aug. 3. Thousand Oaks-based Amgen, one of the world’s largest biotechnology companies, reported earnings per share of 81 cents for the quarter ended June 30, down from $3.05 per share in the same quarter last year. According to Read More →

Latest

Amgen to buy biotech startup TeneoBio

By   /  Tuesday, July 27th, 2021  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, left, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen to buy biotech startup TeneoBio

Amgen announced July 27 that it plans to buy a privately held Bay Area biotech company called TeneoBio in an all-cash deal worth as much as $2.5 billion. The deal is expected to close in the second half of this year and calls for Amgen to pay $900 million up front for all outstanding shares Read More →

Latest

Speedy cancer care matters, now more than ever, Thousand Oaks’ Rabble Health finds in new study

By   /  Friday, July 23rd, 2021  /  Health Care & Life Science, Latest news, Subscriber content  /  Comments Off on Speedy cancer care matters, now more than ever, Thousand Oaks’ Rabble Health finds in new study

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

FDA accuses Amgen of misleading advertising

By   /  Friday, July 16th, 2021  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on FDA accuses Amgen of misleading advertising

The U.S. Food and Drug Administration tagged Amgen with a letter July 7 that says the Thousand Oaks biotech firm made “misleading claims” in advertisements for its drug Neulasta, by suggesting it is more effective than biosimilar competitors. Neulasta is a prescription medication used to reduce infection risk from febrile neutropenia (a low level of Read More →

Latest

FDA gives Amgen priority review for asthma treatment

By   /  Friday, July 9th, 2021  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on FDA gives Amgen priority review for asthma treatment

Thousand Oaks-based Amgen received a priority review for tezepelumab, a treatment for asthma, from the U.S. Food and Drug Administration, the biotech giant announced July 7. According to Amgen, tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population of clients in phase 2 and 3 trials. Read More →

Latest

Amgen’s new drug could be a blockbuster

By   /  Friday, June 4th, 2021  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, right, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen’s new drug could be a blockbuster

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.